Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia
Authors
Keywords
-
Journal
GENES AND IMMUNITY
Volume 13, Issue 2, Pages 109-119
Publisher
Springer Nature
Online
2011-09-01
DOI
10.1038/gene.2011.58
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
- (2011) María Mittelbrunn et al. Nature Communications
- Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis
- (2010) T. T. Lin et al. BLOOD
- The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
- (2010) Ulf Klein et al. CANCER CELL
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
- (2010) J. F. Wiggins et al. CANCER RESEARCH
- The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia
- (2010) Erica Salerno et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- miRNAs as molecular biomarkers of cancer
- (2010) Muller Fabbri EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Emerging paradigms of regulated microRNA processing
- (2010) M. A. Newman et al. GENES & DEVELOPMENT
- Small RNAs Guide Hematopoietic Cell Differentiation and Function
- (2010) F. Navarro et al. JOURNAL OF IMMUNOLOGY
- Functional delivery of viral miRNAs via exosomes
- (2010) D. M. Pegtel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression
- (2009) A. K. Ghosh et al. BLOOD
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- MicroRNA and leukemia: Tiny molecule, great function
- (2009) Haifeng Zhao et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1
- (2009) Mikael Lerner et al. EXPERIMENTAL CELL RESEARCH
- Single-cell analysis reveals oligoclonality among ‘low-count’ monoclonal B-cell lymphocytosis
- (2009) M C Lanasa et al. LEUKEMIA
- Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity
- (2009) E. Salerno et al. MOLECULAR CANCER THERAPEUTICS
- Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes
- (2009) Fumitaka Takeshita et al. MOLECULAR THERAPY
- Regression of murine lung tumors by the let-7 microRNA
- (2009) P Trang et al. ONCOGENE
- MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications
- (2008) M Fabbri et al. LEUKEMIA
- The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
- (2008) Désirée Bonci et al. NATURE MEDICINE
- MiR-15a and miR-16-1 cluster functions in human leukemia
- (2008) George A. Calin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic profiling of exosomes: Current perspectives
- (2008) Richard J. Simpson et al. PROTEOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started